341 related articles for article (PubMed ID: 33123994)
1. Purinergic Signaling Within the Tumor Microenvironment.
Draganov D; Lee PP
Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
[TBL] [Abstract][Full Text] [Related]
2. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
[TBL] [Abstract][Full Text] [Related]
3. Purinergic Signaling in the Hallmarks of Cancer.
Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
[TBL] [Abstract][Full Text] [Related]
4. Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.
Aria H; Rezaei M; Nazem S; Daraei A; Nikfar G; Mansoori B; Bahmanyar M; Tavassoli A; Vakil MK; Mansoori Y
Front Immunol; 2022; 13():947885. PubMed ID: 36072596
[TBL] [Abstract][Full Text] [Related]
5. ATP and cancer immunosurveillance.
Kepp O; Bezu L; Yamazaki T; Di Virgilio F; Smyth MJ; Kroemer G; Galluzzi L
EMBO J; 2021 Jul; 40(13):e108130. PubMed ID: 34121201
[TBL] [Abstract][Full Text] [Related]
6. Microglia and the Purinergic Signaling System.
Calovi S; Mut-Arbona P; Sperlágh B
Neuroscience; 2019 May; 405():137-147. PubMed ID: 30582977
[TBL] [Abstract][Full Text] [Related]
7. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles in cancer immune responses: roles of purinergic receptors.
Graner MW
Semin Immunopathol; 2018 Sep; 40(5):465-475. PubMed ID: 30209547
[TBL] [Abstract][Full Text] [Related]
9. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.
Di Virgilio F; Sarti AC; Falzoni S; De Marchi E; Adinolfi E
Nat Rev Cancer; 2018 Oct; 18(10):601-618. PubMed ID: 30006588
[TBL] [Abstract][Full Text] [Related]
11. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.
Dillard C; Borde C; Mohammad A; Puchois V; Jourdren L; Larsen AK; Sabbah M; Maréchal V; Escargueil AE; Pramil E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768902
[TBL] [Abstract][Full Text] [Related]
12. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
13. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine purinergic signaling in the most lethal types of cancer.
Reyna-Jeldes M; Díaz-Muñoz M; Madariaga JA; Coddou C; Vázquez-Cuevas FG
Purinergic Signal; 2021 Sep; 17(3):345-370. PubMed ID: 33982134
[TBL] [Abstract][Full Text] [Related]
15. P2X7 is a cytotoxic receptor….maybe not: implications for cancer.
Di Virgilio F
Purinergic Signal; 2021 Mar; 17(1):55-61. PubMed ID: 33011962
[TBL] [Abstract][Full Text] [Related]
16. P2Y
Morrone FB; Vargas P; Rockenbach L; Scheffel TB
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684726
[TBL] [Abstract][Full Text] [Related]
17. The participation of plasma membrane hemichannels to purinergic signaling.
Baroja-Mazo A; Barberà-Cremades M; Pelegrín P
Biochim Biophys Acta; 2013 Jan; 1828(1):79-93. PubMed ID: 22266266
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease.
Ahmad S; Ahmad A; White CW
Free Radic Biol Med; 2006 Jul; 41(1):29-40. PubMed ID: 16781450
[TBL] [Abstract][Full Text] [Related]
19. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
20. P2X receptors in cancer growth and progression.
Di Virgilio F; Vultaggio-Poma V; Sarti AC
Biochem Pharmacol; 2021 May; 187():114350. PubMed ID: 33253643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
